Canaccord analyst Kyle Mikson lowered the firm’s price target on Illumina to $285 from $300 and keeps a Buy rating on the shares. The firm said their price target decrease is driven by reduced near-term estimates given the company’s 2Q23 update where the company’s 2Q23 financial results and departure of its CTO and CMO do not appear highly favorable.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ILMN: